Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,075 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

for
AAA, AAA - Abdominal Aortic Aneurysm
Location: Houston TX, Galveston TX, Little Rock AR,
Sponsor: Endologix

Sex: All

Age: 21+

Code: NCT05064540

Recruiting
Active & Responsive

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

for
Relapsed Refractory Multiple Myeloma
Location: Houston TX, Austin TX, Nashville TN, Atlanta GA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07391657

Phase3, Recruiting
Active & Responsive

ALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy

for
BAG3 Mutation Associated Dilated Cardiomyopathy
Location: Houston TX, Birmingham AL, Cincinnati OH,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18 - 70

Code: NCT07218887

Phase1, Phase2, Recruiting
Active & Responsive

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

for
Kidney Disease
Location: Houston TX, Katy TX, San Antonio TX, Shreveport LA,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06963827

Phase3, Recruiting
Active & Responsive

A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment

for
Primary Biliary Cholangitis
Location: Houston TX, Dallas TX, McAllen TX, Englewood CO,
Sponsor: Ipsen

Sex: All

Age: 0+

Code: NCT06447168

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis

for
Myasthenia Gravis
Location: Houston TX, Altamonte Springs FL, Naples FL,
Sponsor: ImmunAbs Inc.

Sex: All

Age: 18 - 70+

Code: NCT07250750

Phase1, Phase2, Recruiting
Active & Responsive

IscadorĀ® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma

for
Osteogenic Sarcoma Recurrent
Location: Houston TX, Hackensack NJ
Sponsor: Hackensack Meridian Health

Sex: All

Age: 8 - 30

Code: NCT05726383

Phase2, Recruiting
Active & Responsive

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

for
Ovarian Cancer, Fallopian Tube Cancer
Location: Houston TX, St Louis MO, Rochester MN, Philadelphia PA,
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT05287451

Recruiting
Active & Responsive

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

for
Metastatic Dedifferentiated Liposarcoma,
Location: Houston TX, Oklahoma City OK, Nashville TN, St Louis MO,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06422806

Phase3, Recruiting
Active & Responsive

A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

for
AML, MDS
Location: Houston TX, Austin TX, Dallas TX, Nashville TN,
Sponsor: TScan Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05473910

Phase1, Recruiting
Active & Responsive

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

for
Autoimmune Disease, Crohn Disease, Dermatomyositis,
Location: Houston TX, Dallas TX, Fort Worth TX, Richardson TX,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03816345

Phase1, Recruiting
Active & Responsive

Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

for
Surgery-Complications, Anesthesia Complication,
Location: Houston TX, Dallas TX, Little Rock AR, St Louis MO,
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT05991453

Recruiting
Active & Responsive

First-in-Human Study of Mutant-selective PI3KĪ± Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

for
PIK3CA Mutation, Solid Tumor, Adult,
Location: Houston TX, Dallas TX, Nashville TN, St Louis MO,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05216432

Phase1, Recruiting
Active & Responsive

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

for
Myelofibrosis; Anemia, Anemia, Myelofibrosis,
Location: Houston TX, St Louis MO, Atlanta GA, Tampa FL,
Sponsor: Disc Medicine, Inc

Sex: All

Age: 18+

Code: NCT05320198

Phase1, Phase2, Recruiting
Active & Responsive

Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women

for
Ovarian Cancer
Location: Houston TX, San Antonio TX, Oklahoma City OK,
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 50 - 70+

Code: NCT00539162

Recruiting
Active & Responsive

Use of Nicotine Pouches Among Daily Smokers

for
Tobacco Dependence
Location: Houston TX, Hershey PA
Sponsor: Milton S. Hershey Medical Center

Sex: All

Age: 21 - 70

Code: NCT06043362

Recruiting
Active & ResponsiveNew

Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL

for
Hodgkin Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 2 - 21

Code: NCT07551583

Phase2, Recruiting
Active & ResponsiveNew

Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous Angiosarcoma

for
Cutaneous Angiosarcoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07655570

Phase2, Recruiting
Active & ResponsiveNew

Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]

for
Colorectal Cancer, Regorafenib, High Risk Patients
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07071961

Phase2, Recruiting
Active & ResponsiveNew

Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)

for
Melanoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06683755

Phase1, Phase2, Recruiting